Massachusetts General Hospital at American Urological Association's 2019 Annual Meeting

Specialists from the Massachusetts General Hospital Department of Urology will present on leading research and innovative treatment approaches.

Featured topics include:

• Renal cell carcinoma
• Renal stones
• Stone disease
• Stone prevention
• Prostate cancer
• Prostatectomy
• Incontinence
• Urolithiasis
• Muscle-invasive bladder cancer treatment

About Urology at Mass General

The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments in every specialty of male and female urology. U.S. News & World Report consistently ranks the Mass General Department of Urology among the best in the nation.

Each year, our doctors perform over 5,000 surgeries and procedures to treat the full spectrum of urological conditions, including:

• All genitourinary cancers
• Kidney stones
• Infertility
• Voiding dysfunctions, such as incontinence
• Prostate-related diseases (e.g., cancer)
• Neuro-urology
• Female urology
• General urology

Our department is a recognized leader in investigating the causes of prostate and bladder cancer and developing preventative methods, treatments and cures for various urological diseases and disorders.

Michael L. Blute, MD, chief of the Department of Urology

Moderator

• Survivor Debate: 3.5 cm Renal Mass in a 71-Year-Old Healthy Man
• Poster Session:
  •  Kidney Cancer: Localized: Surgical Therapy III

Douglas M. Dahl, MD, chief of the Division of Urologic Oncology

Speaker/Faculty

• Prostate Cancer Update

Brian Eisner, MD, co-director of the Kidney Stone Program

Instructional Course Faculty

• Urolithiasis: Metabolic Evaluation and Medical Treatment
• Pesadillas en Endourología - 'Nightmares in Endourology' (Curso en Español)

Podium Session Moderator

• Stone Disease-Epidemiology II

Panelist

• Complex Cases: Stone Prevention: Diet and Medication

Francis J. McGovern, MD, urologist 

Instructional Course

• Opioid-Sparing Analgesia for Enhanced Recovery After Urological Surgery

Adam S. Feldman, MD, MPH, urologic oncologist, Jason Efstathiou, MD, DPhil, director of the Genitourinary Service, Richard Lee, MD, PhD, assistant physician in the Department of Medicine

Instructional Course

• Trimodality Therapy for Management of Muscle-invasive Bladder Cancer

Ajay Singla, MD, FACS, FRCS, director of the Harvard Urologic Surgery Residency Program

Instructional Course

• Surgical Approach to the Management of Post-prostatectomy Incontinence – Initial and Revision Procedures

Melissa Huynh, MD, Urology Service fellow

Podium

• Cell Cycle Genetic Variants Associated with Aggressive Prostate Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Melissa Huynh, MD, Urology Service fellow, Dan Pucheril, MD, urologist, Dimitar Zlatev, MD, urologist

Podium

• Developing a Comorbidity Risk Score to Predict Complications After Partial Nephrectomy for Localized Renal Cell Carcinoma.

Dayron Rodriguez, MD, MPH, Urology resident, Kai Li, MD, Urologic Surgery resident, et al

Moderated Poster

• Epidemiology of Penile Fractures in the Emergency Setting in the United States: Access to Care and Health Care Inequality May Lead to Suboptimal Outcomes

Tammer Yamany, MD, urologist, Michal Ursiny, MD, Surgery/Urology resident, Brian Eisner, MD, co-director of the Kidney Stone Program

Podium/Poster

• Economic Evaluation of Stentless vs. Stented Ureteroscopy and Laser Lithotripsy

Alice Yu, MD, Urologic Oncology fellow

Podium

• Widespread Use of Multiparametric MRI in an Active Surveillance Cohort Results in Earlier Identification and Treatment of Clinically Significant Prostate Cancer

Edouard Nicaise, research assistant in the Department of Urology

Moderated Poster

• Need for Intervention and Survival in a Cohort of Patients on Active Surveillance for Prostate Cancer